ORTHOPEDIATRICS CORP Selling and Marketing Expense in USD from 2015 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The aggregate total amount of expenses directly related to the marketing or selling of products or services.
Summary
Orthopediatrics Corp quarterly/annual Selling and Marketing Expense history and growth rate from 2015 to Q3 2025.
  • Orthopediatrics Corp Selling and Marketing Expense for the quarter ending September 30, 2025 was $18.7M, a 11.4% increase year-over-year.
  • Orthopediatrics Corp Selling and Marketing Expense for the twelve months ending September 30, 2025 was $71.1M, a 17.9% increase year-over-year.
  • Orthopediatrics Corp annual Selling and Marketing Expense for 2024 was $64.3M, a 21.7% increase from 2023.
  • Orthopediatrics Corp annual Selling and Marketing Expense for 2023 was $52.8M, a 14.6% increase from 2022.
  • Orthopediatrics Corp annual Selling and Marketing Expense for 2022 was $46.1M, a 16.2% increase from 2021.
Selling and Marketing Expense, Trailing 12 Months (USD)
Selling and Marketing Expense, Quarterly (USD)
Selling and Marketing Expense, YoY Quarterly Growth (%)
Selling and Marketing Expense, Annual (USD)
Selling and Marketing Expense, YoY Annual Growth (%)

ORTHOPEDIATRICS CORP Quarterly Selling and Marketing Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $71.1M $18.7M +$1.9M +11.4% Jul 1, 2025 Sep 30, 2025 10-Q 2025-10-29
Q2 2025 $69.2M $19.1M +$2.51M +15.1% Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-06
Q1 2025 $66.7M $16.6M +$2.4M +17% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-08
Q4 2024 $64.3M $16.8M +$3.98M +31.1% Oct 1, 2024 Dec 31, 2024 10-K 2025-03-05
Q3 2024 $60.3M $16.8M +$2.81M +20.1% Jul 1, 2024 Sep 30, 2024 10-Q 2025-10-29
Q2 2024 $57.5M $16.6M +$3.06M +22.6% Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-06
Q1 2024 $54.4M $14.2M +$1.62M +12.9% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-08
Q4 2023 $52.8M $12.8M +$814K +6.79% Oct 1, 2023 Dec 31, 2023 10-K 2025-03-05
Q3 2023 $52M $13.9M +$2.02M +17% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 $50M $13.5M +$1.1M +8.87% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-06
Q1 2023 $48.9M $12.5M +$2.79M +28.6% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 $46.1M $12M +$2M +20% Oct 1, 2022 Dec 31, 2022 10-K 2025-03-05
Q3 2022 $44.1M $11.9M +$2.06M +20.9% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 $42M $12.4M +$1.56M +14.3% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-01
Q1 2022 $40.5M $9.76M +$809K +9.04% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-02
Q4 2021 $39.7M $9.99M +$553K +5.86% Oct 1, 2021 Dec 31, 2021 10-K 2024-03-08
Q3 2021 $39.1M $9.86M +$625K +6.77% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-01
Q2 2021 $38.5M $10.9M +$5.26M +93.5% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 $33.2M $8.95M +$1.39M +18.3% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 $31.9M $9.43M +$1.07M +12.8% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-01
Q3 2020 $30.8M $9.24M +$466K +5.31% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 $30.3M $5.62M -$1.99M -26.1% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 $32.3M $7.56M +$1.02M +15.5% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 $31.3M $8.36M +$1.8M +27.5% Oct 1, 2019 Dec 31, 2019 10-K 2022-03-03
Q3 2019 $29.5M $8.77M +$1.62M +22.7% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 $27.9M $7.61M +$830K +12.2% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 $27M $6.55M +$468K +7.7% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-06
Q4 2018 $26.6M $6.56M +$1.16M +21.4% Oct 1, 2018 Dec 31, 2018 10-K 2021-03-11
Q3 2018 $25.4M $7.15M +$1.52M +26.9% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-08
Q2 2018 $23.9M $6.78M +$1.48M +27.9% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-13
Q1 2018 $22.4M $6.08M +$1.89M +45% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
Q4 2017 $20.5M $5.4M Oct 1, 2017 Dec 31, 2017 10-K 2020-03-05
Q3 2017 $5.63M +$1.34M +31.3% Jul 1, 2017 Sep 30, 2017 10-Q 2018-10-31
Q2 2017 $5.3M Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 $4.19M Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-15
Q3 2016 $4.29M Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-13

ORTHOPEDIATRICS CORP Annual Selling and Marketing Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $64.3M +$11.5M +21.7% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-05
2023 $52.8M +$6.73M +14.6% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-05
2022 $46.1M +$6.42M +16.2% Jan 1, 2022 Dec 31, 2022 10-K 2025-03-05
2021 $39.7M +$7.82M +24.5% Jan 1, 2021 Dec 31, 2021 10-K 2024-03-08
2020 $31.9M +$570K +1.82% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-01
2019 $31.3M +$4.72M +17.8% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-03
2018 $26.6M +$6.04M +29.4% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-11
2017 $20.5M +$3.87M +23.2% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-05
2016 $16.7M +$1.63M +10.8% Jan 1, 2016 Dec 31, 2016 10-K 2019-03-07
2015 $15M Jan 1, 2015 Dec 31, 2015 10-K 2018-03-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.